(Q72186020)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6011791%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

title

Considerations for the pre-clinical evaluation of new psychiatric drugs: a case study with phenothiazine-like tranquilizers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6011791%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

S Irwin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6011791%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

publication date

1 January 1966

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6011791%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6011791%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6011791%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

259-287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6011791%20AND%20SRC:MED&resulttype=core&format=json

Pharmacodynamic basis for the use of chlorpromazine in psychiatry.

24 October 2019

cites work

1 reference

12 December 2020

Studies on the diethylamide of lysergic acid (LSD-25). II. Effects of chlorpromazine, azacyclonol, and reserpine on the intensity of the LSD-reaction

1 reference

12 December 2020

Convulsions and bizarre behavior in monkeys receiving chlorpromazine

1 reference

12 December 2020

Perphenazine (trilafon), a new potent tranquilzer and antiemetic. I. Behavioral mode of action

1 reference

12 December 2020

Phenothiazine; pharmacologic studies

1 reference

12 December 2020

Newer phenothiazine drugs in treatment of nervous disorders

1 reference

12 December 2020

Phenothiazine tranquilizers: eight years of development

1 reference

12 December 2020

1 reference

12 December 2020

Fluphenazine: its spectrum of therapeutic application and clinical results in psychiatric patients.

1 reference

12 December 2020

Lithium ion: a specific psychopharmacological approach to the treatment of mania

1 reference

12 December 2020

Drug effects on the behavior of animals

1 reference

12 December 2020

The relationship of drug-induced neurological phenomena on therapeutic outcome

1 reference

12 December 2020

Parkinsonism and related phenomena from administration of drugs: their production and control under clinical conditions and possible relation to therapeutic effect.

1 reference

12 December 2020

Influence of external factors and arousal mechanisms on the rate of drug tolerance development

1 reference

12 December 2020

Use of newer psychopharmacological drugs for pharmacological screening

1 reference

12 December 2020

Inhibition of Tremorine by a Group of Non-anti-Parkinson Phenothiazine Derivatives

1 reference

12 December 2020

ESCAPE BEHAVIOR AND PUNISHED BEHAVIOR

1 reference

12 December 2020

EFFECTS OF DRUGS ON AVOIDANCE AND ESCAPE BEHAVIOR

1 reference

12 December 2020

IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS

1 reference

12 December 2020

Drug Screening and Evaluative Procedures: Current approaches do not provide the information needed for properly predicting drug effects in man

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00408328

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6011791%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6011791%20AND%20SRC:MED&resulttype=core&format=json